{
     "PMID": "6190101",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "19830708",
     "LR": "20131121",
     "IS": "0028-3908 (Print) 0028-3908 (Linking)",
     "VI": "22",
     "IP": "3 Spec No",
     "DP": "1983 Mar",
     "TI": "Chronic antidepressant treatment and central 5-HT synapses.",
     "PG": "389-400",
     "AB": "The present studies have shown that chronic antidepressant treatment with desipramine, imipramine, zimelidine and alaproclate led to adaptive changes in both pre- and postsynaptic 5-hydroxytryptamine (5-HT) receptor mechanisms which appear to result in 5-HT sub- or supersensitivity development depending upon the 5-HT nerve terminal systems analyzed. The results underline the heterogeneity of the central 5-HT neurone systems in their responses to chronic antidepressant treatment. An involvement of 5-HT comodulators is postulated in the actions of antidepressants on central 5-HT synapses. Finally, the results point to the importance of 5-HT neurone systems as targets for the action for antidepressant drugs and they may mediate at least some of the therapeutic activity of antidepressant drugs.",
     "FAU": [
          "Fuxe, K",
          "Ogren, S O",
          "Agnati, L F",
          "Benfenati, F",
          "Fredholm, B",
          "Andersson, K",
          "Zini, I",
          "Eneroth, P"
     ],
     "AU": [
          "Fuxe K",
          "Ogren SO",
          "Agnati LF",
          "Benfenati F",
          "Fredholm B",
          "Andersson K",
          "Zini I",
          "Eneroth P"
     ],
     "LA": [
          "eng"
     ],
     "GR": [
          "MH 25504/MH/NIMH NIH HHS/United States"
     ],
     "PT": [
          "Journal Article",
          "Research Support, U.S. Gov't, P.H.S.",
          "Review"
     ],
     "PL": "England",
     "TA": "Neuropharmacology",
     "JT": "Neuropharmacology",
     "JID": "0236217",
     "RN": [
          "0 (Antidepressive Agents)",
          "0 (Carrier Proteins)",
          "0 (Pituitary Hormones, Anterior)",
          "0 (Receptors, Drug)",
          "0 (Receptors, Neurotransmitter)",
          "0 (Receptors, Serotonin)",
          "0 (imipramine receptor)",
          "333DO1RDJY (Serotonin)",
          "33507-63-0 (Substance P)",
          "4X6E73CJ0Q (Spiperone)",
          "60106-89-0 (Dihydroalprenolol)",
          "8NA5SWF92O (Lysergic Acid Diethylamide)",
          "E0399OZS9N (Cyclic AMP)",
          "OGG85SX4E4 (Imipramine)",
          "W980KJ009P (Corticosterone)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Antidepressive Agents/*pharmacology",
          "*Carrier Proteins",
          "Corticosterone/secretion",
          "Cyclic AMP/metabolism",
          "Dihydroalprenolol/metabolism",
          "Hippocampus/metabolism",
          "Humans",
          "Imipramine/metabolism",
          "Lysergic Acid Diethylamide/metabolism",
          "Pituitary Hormones, Anterior/secretion",
          "*Receptors, Drug",
          "Receptors, Neurotransmitter/analysis",
          "Receptors, Serotonin/analysis/*drug effects",
          "Serotonin/metabolism",
          "Spiperone/metabolism",
          "Substance P/pharmacology"
     ],
     "RF": "44",
     "EDAT": "1983/03/01 00:00",
     "MHDA": "1983/03/01 00:01",
     "CRDT": [
          "1983/03/01 00:00"
     ],
     "PHST": [
          "1983/03/01 00:00 [pubmed]",
          "1983/03/01 00:01 [medline]",
          "1983/03/01 00:00 [entrez]"
     ],
     "PST": "ppublish",
     "SO": "Neuropharmacology. 1983 Mar;22(3 Spec No):389-400.",
     "term": "hippocampus"
}